Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity

Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity

ABSTRACT Background Advanced pancreatic ductal adenocarcinoma (aPDAC) is often accompanied by significant muscle mass loss, contributing to poor prognosis. SarcAPACaP, an ancillary study of the GERCOR‐APACaP phase III trial, evaluated the role of adapted physical activity (APA) in aPDAC Western pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Pauline Parent, Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie‐Line Garcia Larnicol, Dewi Vernerey, Alain Luciani, Pascal Hammel, Julie Henriques, Cindy Neuzillet, Anthony Turpin
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
adapted physical activity
CT scan
muscular mass loss
pancreatic cancer
quality of life
sarcopenia
Online Access:https://doi.org/10.1002/jcsm.13595
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jcsm.13595

Similar Items